Specific viral antibodies associate with anti-NMDAR encephalitis after herpes simplex encephalitis.

Saved in:
Bibliographic Details
Title: Specific viral antibodies associate with anti-NMDAR encephalitis after herpes simplex encephalitis.
Authors: Kreye J; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Pediatric Neurology, Berlin, Germany; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurology and Experimental Neurology, Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany; Institute for Cell Engineering, Division of Immunology, Department of Pathology, Johns Hopkins University, Baltimore, MD, USA. Electronic address: jakob.kreye@charite.de., Morgenlander WR; Institute for Cell Engineering, Division of Immunology, Department of Pathology, Johns Hopkins University, Baltimore, MD, USA., Thakar M; Institute for Cell Engineering, Division of Immunology, Department of Pathology, Johns Hopkins University, Baltimore, MD, USA., Schulte-Frankenfeld PM; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Pediatric Neurology, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany., Schott S; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Pediatric Neurology, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany., Bünger I; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Pediatric Neurology, Berlin, Germany; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurology and Experimental Neurology, Berlin, Germany., Kornau HC; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Neuroscience Research Center (NWFZ), Berlin, Germany., Angkeow JW; Institute for Cell Engineering, Division of Immunology, Department of Pathology, Johns Hopkins University, Baltimore, MD, USA., Jayaraman S; Institute for Cell Engineering, Division of Immunology, Department of Pathology, Johns Hopkins University, Baltimore, MD, USA., Otto C; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurology and Experimental Neurology, Berlin, Germany., Hahn W; Department of Neurology, Epilepsy Center, Philipps-University Marburg, Marburg, Germany., Lewerenz J; Department of Neurology, Ulm University, Ulm, Germany., Thaler FS; Institute of Clinical Neuroimmunology, LMU University Hospital, LMU Munich, Biomedical Center (BMC), Faculty of Medicine, Germany., Korporal-Kuhnke M; Department of Neurology, University of Heidelberg, Heidelberg, Germany., Melzer N; Department of Neurology, Medical Faculty and University Hospital, Heinrich Heine University of Düsseldorf, Düsseldorf, Germany., Dargvainiene J; Institute of Clinical Chemistry, University Hospital Schleswig-Holstein (UKSH), Christian-Albrechts-University (CAU), Kiel, Germany., Bien CG; Department of Epileptology, Krankenhaus Mara, Bethel Epilepsy Center, Medical School OWL, Bielefeld University, Bielefeld, Germany; Laboratory Krone, Bad Salzuflen, Germany., Kohlie R; Institute for Experimental Immunology, Affiliated with EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany., Lattwein E; Institute for Experimental Immunology, Affiliated with EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany., Schmitz D; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Neuroscience Research Center (NWFZ), Berlin, Germany., Calabresi PA; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Pardo CA; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Prüss H; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurology and Experimental Neurology, Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany., Ruprecht K; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurology and Experimental Neurology, Berlin, Germany., Benjamin Larman H; Institute for Cell Engineering, Division of Immunology, Department of Pathology, Johns Hopkins University, Baltimore, MD, USA. Electronic address: hlarman1@jhmi.edu.
Source: Brain, behavior, and immunity [Brain Behav Immun] 2025 Nov; Vol. 130, pp. 106073. Date of Electronic Publication: 2025 Aug 11.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8800478 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2139 (Electronic) Linking ISSN: 08891591 NLM ISO Abbreviation: Brain Behav Immun Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1090-2139
DOI:10.1016/j.bbi.2025.106073